» Articles » PMID: 21106855

Sepsis Induces Early Alterations in Innate Immunity That Impact Mortality to Secondary Infection

Abstract

Sepsis, the systemic inflammatory response to microbial infection, induces changes in both innate and adaptive immunity that presumably lead to increased susceptibility to secondary infections, multiorgan failure, and death. Using a model of murine polymicrobial sepsis whose severity approximates human sepsis, we examined outcomes and defined requirements for survival after secondary Pseudomonas aeruginosa pneumonia or disseminated Listeria monocytogenes infection. We demonstrate that early after sepsis neutrophil numbers and function are decreased, whereas monocyte recruitment through the CCR2/MCP-1 pathway and function are enhanced. Consequently, lethality to Pseudomonas pneumonia is increased early but not late after induction of sepsis. In contrast, lethality to listeriosis, whose eradication is dependent upon monocyte/macrophage phagocytosis, is actually decreased both early and late after sepsis. Adaptive immunity plays little role in these secondary infectious responses. This study demonstrates that sepsis promotes selective early, impaired innate immune responses, primarily in neutrophils, that lead to a pathogen-specific, increased susceptibility to secondary infections.

Citing Articles

Induction of endotoxin tolerance in murine monocyte and macrophage cell populations - optimal LPS dose and compartment-specific reversal by β-glucan.

Moerings B, Govers C, van Bergenhenegouwen J, Mes J, van Dijk M, Witkamp R Food Funct. 2025; 16(4):1576-1587.

PMID: 39917820 PMC: 11803501. DOI: 10.1039/d4fo05223d.


Immunoadjuvant therapy in the regulation of cell death in sepsis: recent advances and future directions.

Islam M, Watanabe E, Salma U, Ozaki M, Irahara T, Tanabe S Front Immunol. 2024; 15:1493214.

PMID: 39720718 PMC: 11666431. DOI: 10.3389/fimmu.2024.1493214.


Macrophage activation syndrome in Sepsis: from pathogenesis to clinical management.

Chen S, Zhang C, Luo J, Lin Z, Chang T, Dong L Inflamm Res. 2024; 73(12):2179-2197.

PMID: 39404874 DOI: 10.1007/s00011-024-01957-7.


Ex Vivo Endotoxin Stimulation of Blood for Predicting Survival in Patients With Sepsis: A Systematic Review.

Wheelwright J, Halstead E, Knehans A, Bonavia A CHEST Crit Care. 2023; 1(3).

PMID: 38148988 PMC: 10751038. DOI: 10.1016/j.chstcc.2023.100029.


Effect of ethanol exposure on innate immune response in sepsis.

Roychowdhury S, Pant B, Cross E, Scheraga R, Vachharajani V J Leukoc Biol. 2023; 115(6):1029-1041.

PMID: 38066660 PMC: 11136611. DOI: 10.1093/jleuko/qiad156.


References
1.
Nathan C . Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006; 6(3):173-82. DOI: 10.1038/nri1785. View

2.
Tracey K, Cerami A . Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994; 45:491-503. DOI: 10.1146/annurev.med.45.1.491. View

3.
Livingston D, Appel S, Wellhausen S, Sonnenfeld G, Polk Jr H . Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg. 1988; 123(11):1309-12. DOI: 10.1001/archsurg.1988.01400350023002. View

4.
Hotchkiss R, Karl I . The pathophysiology and treatment of sepsis. N Engl J Med. 2003; 348(2):138-50. DOI: 10.1056/NEJMra021333. View

5.
Cyster J . Lymphoid organ development and cell migration. Immunol Rev. 2003; 195:5-14. DOI: 10.1034/j.1600-065x.2003.00075.x. View